Page 49 - MEMOCiberesp014-ENG

We attended the following events:
• European Infrastructure Conference, ESFRI, ISCIII, January 2014, Madrid . • H2020 NMP Conference, February 2014, Madrid . • Annual Meeting of Biomedicine Platforms, March 2014, Barcelona . • Annual CEBR Meeting, April 2014, Coimbra (Portugal) .
• Internal CTLS Congress, June 2014, Paris . • Biospain, September 2014, Santiago de Compostela . • ETPN Annual Meeting, October 2014, San Sebastián . • Brokerage Event Nanofutures, November 2014, Brussels .
The process for becoming an ICTS (Singular Scientific and Technological Infrastructure) was successfully culminated . A response to allegations with respect to a series of comments about the request submitted by CIBER-BBN together with the Centro de Cirugía de Mínima Invasion Jesús Usón (Cáceres) for recognition of research service infrastructure of both entities as a Singular Scientific and Technological Infrastructure (ICTS) was prepared in 2014 . Said request was favourably resolved in October 2014, and NANBIOSIS (Infrastruc- ture for the Production and Characterization of Nanomaterials, Biomaterials and Systems for application in Biomedicine) was recognized as an ICTS . Furthermore, several meetings were held with MINECO . The Consolidation Agreements as an ICTS between both Centres was written, and work is being done on said consolidation process . Actions were instituted to create a web page, informative dossier, etc .
Information about the programme on the web page has been permanently updated such that the most recent information about the services and conditions are available for internal and external research groups and companies .
Follow up on collaborations that started with companies was performed . Some examples are the PHYTECH project (INNPACTO programme), in which two Spanish companies and a unit (Surface Characterization and Calorimetry) are involved, the European project called BERENICE (Benznidazole and triazole nanoformula- tion for treating Chagas disease), involving 2 units (Molecular Biomaterial Processing and Nanostructuring Unit and the Drug Formulation Unit), or the project called TERET (RETOS-COLABORACIÓN programme), which includes the participation of two companies (Sylentis and LeadArtis) together with the Drug Formu- lation Unit and two more CIBER-BBN groups, among others .
The new strategic action launched in 2011 to improve equipment platforms for developing collaboration projects with companies and with the participation of one or more Programme units continued in 2014 .
In an attempt to promote collaborations with companies, making our services more appealing, the line for supporting ISO 9001 standard certification for interested units was continued . It was consolidated in 2014 with the certification process of two units (Protein Production Platform and In vivo Experiment Unit) and the process for Nanostructured Liquid Characterization Unit and Surface Characterization Unit began .
Participation in European initiatives was maintained . Some examples are:
• ETP Nanofutures (www .nanofutures .eu) • IN2LifeSciences (IN2LS) • ARBRE (Association of Resources for Biophysical Research in Europe)
www.ciber-bbn.es 49